Effects of Chinese medicine Yuxia capsule on renal fibrosis in spontaneously hypertensive rats

doi:10.12092/j.issn.1009-2501.2018.06.006

Abstract

Abstract:

AIM: To investigate the improvement of Chinese medicine Yuxia capsule on renal fibrosis in spontaneously hypertensive rats (SHR) and its possible mechanism. METHODS: WKYs（Wistar-Kyoto rats）were set as normal control group (0.5% CMC-Na, 5 mL/kg). SHRs were randomly divided into SHR model group (0.5% CMC-Na, 5 mL/kg), Yuxia capsule high dose group (0.6 g/kg), middle dose group (0.3 g/kg) and low dose group (0.15 g/kg). Seven rats in each group. According to the above dose, each group of rats were gavaged once daily for 10 weeks. Diastolic blood pressure (DBP) was measured before administration and 2, 4, 6, 8, 10 weeks during the drug administration by non-invasive tail arterial pressure system. Urine was collected before and 3, 5, 8 week after administration and the urine volume was measured. Automatic biochemical analyzer was utilized to measure the contents of serum creatinine (Scr) and blood urea nitrogen (BUN). Immunohistochemistry was used to detect the levels of TGF-β1 positive cells in kidney. Quantitative reverse transcription PCR (RTqPCR) was applied to detect the expression levels of TGFβ1 mRNA. Western blot was adopted to measure the expressions of ERK1/2，p-ERK1/2，P38，p-P38，MMP-9，TIMP-1 proteins in kidney. RESULTS: Yuxia capsule could dose-dependently reduce DBP and the contents of Scr and BUN, increase urine volume. Expressions of TGF-β1，MMP-9，TIMP-1 and phosphorylation of P38 and ERK1/2 protein level in Yuxia capsule group were lower than those in model group（P<0.05, P<0.01）. CONCLUSION: Traditional Chinese medicine Yuxia capsule demonstrats protective effects against renal fibrosis in a dosedependent manner within a certain range in SHR, of which the mechanism may be associated with reducing diastolic blood pressure, promoting urination, inhibiting P38/MAPK, ERK/MAPK signal pathway and the expressions of TGF-β1，MMP-9 and TIMP-1, recovering the ratio of MMP-9/TIMP-1.

Key words: Yuxia capsule, spontaneous hypertensive rats, renal fibrosis, TGF-β1, P38/MAPK, ERK/MAPK, MMP-9/TIMP-1

CLC Number:

R965.2

CHENG Xiaolong, HU Kunmei, HU Haoran，XU Hanghang, YANG Jieren, HAN Jun. Effects of Chinese medicine Yuxia capsule on renal fibrosis in spontaneously hypertensive rats[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(6): 632-639.

References

［1］Navar LG. The intrarenal reninangiotensin system in hypertension［J］. Kidney Int, 2004, 65(4):1522-1532.
［2］Akhtar S, AlZaid B, ElHashim AZ, et al. Impact of PAMAM delivery systems on signal transduction pathways in vivo: Modulation of ERK1/2 and p38 MAP kinase signaling in the normal and diabetic kidney［J］. Int J Pharm, 2016, 514(2):353-363.
［3］Fu W, Wang Y, Jin Z, et al. Losartan alleviates renal fibrosis by downregulating HIF1α and upregulating MMP9/TIMP1 in rats with 5/6 nephrectomy［J］. Ren Fail, 2012, 34(10):1297-1304.
［4］王建华. 玉夏胶囊配制工艺的研究［J］. 浙江中医杂志, 2011, 46(7):530-531.
［5］郑梅生，朱琳. 玉夏胶囊治疗高血压病526例临床观察［J］. 中医杂志, 2011，52(18):1562-1565.
［6］胡坤媚, 胡浩然, 沈媛媛,等. 中药玉夏胶囊对自发性高血压大鼠肾纤维化的改善作用及TGFβ1/Smads信号通路的影响［J］. 中国临床药理学与治疗学, 2017, 22(4):387-393.
［7］Lu W, Liu S, Zhao Z, et al. The effect of connective tissue growth factor on renal fibrosis and podocyte injury in hypertensive rats ［J］. Ren Fail, 2014, 36(9):1420-1427.
［8］Zhang J, Fallahzadeh MK, Mccullough PA. Aging Male Spontaneously Hypertensive Rat as an Animal Model for the Evaluation of the Interplay between ContrastInduced Acute Kidney Injury and Cardiorenal Syndrome in Humans ［J］. Cardiorenal Med, 2016, 7(1):1-10.
［9］冯青, 万毅刚, 蒋春明,等.中药延缓慢性肾功能衰竭进展的机制和效果［J］.中国中药杂志,2011, 36(9):1122-1128.
［10］刘真，于慧卿，魏运湘.夏枯草汤治疗高血压病及对血管内皮功能的影响［J］.陕西中医，2006，27(2):162-163.
［11］张永和,陈声武,周鸣,等. 莱菔子注射液降压作用的实验研究［J］. 吉林中医药, 1996，6(5):41.
［12］窦传斌, 杜娟, 许启泰. 玉米须多糖的利尿作用研究［J］. 河南大学学报(医学版), 2007, 26(3):35-37.
［13］王欣彤,方祝元.中药干预AngⅡAT1RCTGF通路对高血压早期肾损害影响的研究进展［J］.辽宁中医杂志, 2014, 41(7):1546-1548.
［14］Peng F, Su J, Lin J, et al. Impact of reninangiotensinaldosterone systemblocking agents on the risk of contrastinduced acute kidney injury: a prospective study and meta-analysis［J］. J Cardiovasc Pharmacol, 2015, 65(3):262-268.
［15］Wang M, Chen DQ, Wang MC, et al.Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulointerstitial fibrosis and podocyte injury by inhibiting TGFβ/Smad signaling pathway［J］. Phytomedicine, 2017，(36), 243-253.
［16］赵燕云, 吴小燕, 汪国敏,等. 苯那普利干预Wnt信号通路抑制UUO大鼠肾纤维化的实验研究［J］. 中国临床药理学与治疗学, 2017, 22(12):1332-1339.
［17］Zhao W, Chen SS, Chen Y, et al. Kidney fibrosis in hypertensive rats: role of oxidative stress.［J］. Am J Nephrol, 2008, 28(4): 548-554.
［18］Catania JM, Chen G, Parrish AR. Role of matrix metalloproteinases in renal pathophysiologies［J］. Am J Physiol Renal Physiol, 2007, 292(3):F905-911.
［19］周育锋, 高磊平, 朱莺. 稳肾颗粒对慢性肾衰竭大鼠ERK通路、MMP9和TIMP1表达的影响［J］. 中医药导报, 2016,22(5):75-77.
［20］黄燕如, 万毅刚, 孙伟,等. 雷公藤多苷调节肾组织p38MAPK信号通路改善糖尿病肾病肾小球炎症性损伤的作用和机制［J］. 中国中药杂志, 2014, 39(21):1402-1409.
［21］Fang W, Chen H, Yan Y, et al. Baicalein protects against the development of angiotensin IIinduced abdominal aortic aneurysms by blocking JNK and p38 MAPK signaling［J］. Sci China Life Sci, 2016, 59(9):940-949.
［22］Jang HS, Han SJ, Kim JI, et al. Activation of ERK accelerates repair of renal tubular epithelial cells, whereas it inhibits progression of fibrosis following ischemia/reperfusion injury［J］. Biochim Biophys Acta, 2013, 1832(12):1998-2008.

[1]	LI Shixu, LI Linyun, WANG Xin, LI Ke, BIAN Hua. Effects of Ginkgo biloba extract on renal injury in rats with experimental renal failure through miR-145/FOXO1 axis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 728-735.
[2]	JIN Yiyi, ZHOU Keting, YANG Chengcheng, XU Ping, ZHU Suyan. Osthole attenuates diabetes-induced renal injury by regulating NF-κB and p38/MAPK pathway mediated inflammatory responses [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 622-631.
[3]	ZHANG Xiaoling，GUAN Qiaobin，YANG Yi, GUO Li，HAN Chenyang. Effect of interleukin 12A on proliferation and differentiation of CD4+CD25+Foxp3+Treg [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(5): 496-502.
[4]	HE Yang, SONG Liying, PENG Xiangdong, FANG Weijin, WANG Chunjiang, DENG Zhenzhen, LIU Shikun. Protective effects of Cordyceps sinensis powder on liver injury induced by DEN in rats and the effect of TGF-β1/Smads pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(9): 974-982.
[5]	LI Zhuqing, JU Yinghui, CHEN Qingqing, MA Keke, LI Weiping. Protective effects of Astragaloside Ⅳ on early kidney damage in diabetes mellitus rats and its mechanisms [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(3): 255-262.
[6]	LU Wei, ZHOU Bingrong,TANG Yi, FAN Yibin, TAO Xiaohua. Role of Th17 cells in acne pathogenesis and the correlation with severity of acne [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(1): 83-87.
[7]	HAN Chao, YANG Liu, ZHANG Qiuling, PAN Jinqiang, XU Jun. Effect of baicalin on airway remodeling of bronchial asthma [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(7): 749-754.
[8]	HU Kunmei, HU Haoran, SHEN Yuanyuan, LU Yining, YANG Jieren, HAN Jun. Effect of traditional Chinese medicine Yuxia capsule on renal fibrosis in spontaneously hypertensive rats and its relationship with TGF-β1/Smads signaling pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(4): 387-393.
[9]	LIU Xiaoyun, ZHANG Wen, LI Weiping, GONG Huilin, HAN Jia, LUAN Jiajie. Protective effect of astragalosides on kidney damage in diabetic mice [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(2): 132-138.
[10]	SU Jian, YIN Li-ping, ZHANG Xin, LI Bi-bo, LIU Li, LI Hui. Influence of rhein intervention on the expression of HGF and BMP7 in renal tissue of rats with chronical allograft nephropathy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(10): 1114-1120.
[11]	HUANG Jian-xiong, WU Pei. Significance of ERK/MAPK signal transduction pathway in the targeting treatment of gastrointestinal cancer [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(7): 833-836.
[12]	WANG Jian-yun, YIN Xiao-xing. Relationship between transforming growth factor-β₁ signal transduction and renal fibrosis of diabetes [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(4): 371-376.
[13]	WU Ji-Ning, LIU Bi-Cheng. Current researches of angiotensin receptor blockers in treatment of patients with chronic progressive renal disease [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(11): 1201-1204.